PharmaVoice

JULY 18, 2023

A former WHO epidemiologist is applying lessons learned during the Ebola epidemic to her work leading a company at the forefront of women’s health: the reproductive microbiome.

Leads 52

Leads 52

Pharmaceutical Commerce

JANUARY 15, 2024

FDA approves Keytruda (pembrolizumab) combined with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer, which is the 39th overall approved indication for the drug in the United States.

FDA 107

FDA Patients 107

Pharmacy Times

JANUARY 15, 2024

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

FDA 49

FDA 49

Pharmaceutical Technology

SEPTEMBER 27, 2023

The idiopathic pulmonary fibrosis (IPF) market is underserved with just two licensed pharmaceutical treatments approved by the FDA in 2014.

Patients 105

Patients FDA Pharmaceutical Marketing 105

MedCity News

DECEMBER 26, 2022

The 17% increase is the largest jump since OIG began tracking lab spending in 2014. This increase was due to higher volume for three test types: Covid-19 tests, genetic tests and chemistry tests.

92

92

MedCity News

APRIL 14, 2023

Since Scene Health was founded in 2014, it has raised more than $25 million total. Scene Health’s $17.7 million Series B funding round was led by ABS Capital Partners and includes participation from Claritas Health Ventures, PTX Capital, Kapor Capital and Healthworx, the investment arm of CareFirst BlueCross BlueShield.

Medical 92

Medical 92

PharmExec

MARCH 13, 2024

Data shows that from 2014-2019, pneumococcal vaccinations in seniors increased by 10%, growing sales for Prevnar 13 due to government recommendation in addition to a high-profile advertising campaign.

Government 52

Government Pharmaceutical Sales 52

PharmExec

JANUARY 15, 2024

The FDA issued the 39th overall approval for Keytruda (pembrolizumab), with the latest in combination with chemoradiation for the treatment of patients with FIGO 2014 stage III to IVA cervical cancer.

FDA 52

FDA Patients 52

MedCity News

JUNE 20, 2023

Renee Dua and Nick Desai —the husband-and-wife duo who founded physician house call company Heal in 2014 — have launched another healthcare startup.

Patients 86

Patients Physicians Healthcare Healthcare 86

Pharmacy Times

MAY 20, 2024

In 2014, the cobas human papillomavirus test was approved by the FDA for first-line, primary screening in women aged 25 years and older.

FDA 52

FDA 52

Pharmacy Times

JANUARY 16, 2024

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients.

FDA 58

FDA Patients 58

World of DTC Marketing

JANUARY 10, 2022

Data were mainly accessible for smaller firms, effects in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products approved between 2014 and 2018. According to the study in JAMA “the FDA approved 355 new drugs and biologics over the study period.

Food and Drug Administration 213

Food and Drug Administration Pharma Marketing Food 213

Clarivate

JULY 16, 2024

The figure includes the trend in overall, international and open access output over the period 2014 to 2023 for each member of the G20. Th is includes the output and impact of each G20 member by discipline together with the trends from 2014 to 2023. although the percentage has halved over a decade (2014 – 2023) from 12% to 6%.

Leads 59

Leads Engineering Government Management 59

World of DTC Marketing

DECEMBER 17, 2020

Another 8% said they or a family member put off treatment for a less serious condition, bringing the total percentage of households delaying care due to costs to 33%, tying the high from 2014. As 60 Minutes reported last weekend, one big chain, Sutter, has led to the most expensive childbirth in the U.S.

Healthcare 181

Healthcare Healthcare Government Physicians 181

Spotio

AUGUST 1, 2022

SPOTIO has been helping solar field sales take their teams to the next level and achieve more since 2014. The Complete Guide for Solar Sales Leaders. Today, we work with hundreds of residential and commercial solar companies worldwide.

Sales 98

Sales 98

Pharmacy Times

DECEMBER 15, 2022

While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal.

49

49

European Pharmaceutical Review

SEPTEMBER 12, 2023

The panelists referred to other documents that are useful for CCS development: the 2014 Pharmaceutical Healthcare Sciences Society (PHSS) Technical Monograph No 20 Bio-Contamination 2 as well as the Parenteral Drug Association (PDA) Technical Report 90: Contamination Control Strategy Development, 3 published in February 2023.

Consulting 128

Consulting Biopharma Manufacturing Pharmaceutical 128

World of DTC Marketing

MARCH 31, 2022

In 2014, researchers determined, 30% of insulin revenue went to middlemen. Researchers at USC found that drugmakers’ share of revenue from insulin sales has declined in recent years — and a more significant share is being siphoned off by pharmacy benefit managers, drugstores, wholesalers, and insurers. Los Angeles Times.

Insurance 240

Insurance Prescription Manufacturing Sales 240

Pharmacy Times

NOVEMBER 11, 2022

Updated prescribing guidelines issued in 2014 and 2016 may explain lower use of opioids by 11.7% among patients with chronic, nonsurgical pain.

Patients 49

Patients 49

European Pharmaceutical Review

NOVEMBER 2, 2022

The UK’s share of global research and development ( R&D ) investment has fallen by a fifth since 2014, according to recent data analysis by the Institute for Public Policy Research (IPPR). percent in 2014. percent GDP R&D investment. percent to 3.4 IPPR indicated that state investment drives private sector investment.

Government 98

Government Leads Manufacturing Medicine 98

pharmaphorum

NOVEMBER 29, 2022

At NeoImmuneTech, a Biotech company founded in Maryland, US, in 2014, the answer to this question looks straightforward: “We believe in incremental progress”, says Dr Se Hwan Yang, president and chief executive officer of the company. Dr Se Hwan Yang, PhD, President and Chief Executive Officer, founded NeoImmuneTech in January 2014.

Safety 105

Safety Patients Engineering Recruitment 105

World of DTC Marketing

JANUARY 12, 2021

Recent Studies show that in 2014, 70% of the 50-65 age bracket use the internet, while 38% of those over 65 years old go online. For the first time, more than half of all online adults 65 and older (56%) use social media, Facebook in particular, according to Pew Research Center’s Social Media Update for 2014.

Patients 155

Patients Media Marketing Prescription 155

World of DTC Marketing

JANUARY 4, 2022

In 2014, cancer patients paid $4 billion out-of-pocket for cancer treatment. Cancer patients may struggle to pay out-of-pocket expenses due to the high expenses incurred, the medical debt, or loss of work. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Insurance 273

Insurance Transportation Medical Medicine 273

Pharmaceutical Technology

JANUARY 22, 2023

Jardiance was initially approved in 2014 as a once-a-day tablet for use with diet and exercise to reduce blood sugar in type 2 diabetes adult patients. The company stated that the drug received Fast Track designation from the US FDA for the same indication in March 2020.

Food and Drug Administration 105

Food and Drug Administration FDA Food Patients 105

European Pharmaceutical Review

JUNE 8, 2023

1 In the EU, the Tobacco Products Directive (2014/40/EU) governs “the manufacture, presentation and sale of tobacco and related products”. The harmful effects of smoking are well known, causing more avoidable deaths than any other single cause. Internet] OJEU. Cited 2022Mar].

Food and Drug Administration 59

Food and Drug Administration FDA Manufacturing Law & Regulation 59

pharmaphorum

NOVEMBER 27, 2022

. “If I had had that information at the beginning, I could have avoided the treatments I received that were never going to work,” added Stephen who was diagnosed with metastatic breast cancer in March 2014. “It would have saved me and the NHS a lot of money. It would have avoided false hope.”

Patients 87

Patients Medicine Government Leads 87

pharmaphorum

JANUARY 3, 2023

After passing on the reins of NICE, he was appointed chair of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), heading up the agency for two 3-year terms between 2014 and 2020.

Side effects 52

Side effects Medicine Safety Healthcare 52

European Pharmaceutical Review

APRIL 29, 2024

Pfizer licensed BEQVEZ from Spark Therapeutics in December 2014. “A one-time treatment with BEQVEZ has the potential to be transformative for appropriate patients by reducing both the medical and treatment burden over the long term.” BEQVEZ is currently being reviewed by the European Medicines Agency (EMA), Pfizer confirmed.

Food and Drug Administration 96

Food and Drug Administration Medicine FDA Food 96

World of DTC Marketing

MAY 26, 2021

net revenue for Imbruvica has increased from $492 million in 2014 to $4.3 billion in Imbruvica net revenue from Medicare Part D between 2014 and 2018. AbbVie’s yearly U.S. net revenue from Humira more than tripled from $5.3 billion in 2013—the year it separated from Abbott—to $16.1 billion in 2020. billion in 2020. AbbVie’s U.S.

Competition 180

Competition Marketing Government Patients 180

Pharma Leaders

JUNE 27, 2023

Pfizer obtained the licence for gene therapy from Spark Therapeutics in December 2014. Fidanacogene elaparvovec also demonstrated to be well-tolerated, with a safety profile in line with Phase I/II data.

Food and Drug Administration 52

Food and Drug Administration FDA Safety Engineering 52

European Pharmaceutical Review

JULY 26, 2024

The pharmaceutical company licensed the gene therapy DURVEQTIX from Spark ® Therapeutics in December 2014. The company highlighted that the median annualised bleed rate (ABR) of zero bleeds was observed in the haemophilia B patients after up to four years of follow-up, Pfizer shared.

Food and Drug Administration 52

Food and Drug Administration Engineering Food Patients 52

European Pharmaceutical Review

NOVEMBER 2, 2022

The advanced facility will be based on the Regenerative Medicine Clinic established at Cedars-Sinai in 2014, developing clinical trials for neurological, cardiovascular, musculoskeletal and autoimmune diseases. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project.

Food and Drug Administration 98

Food and Drug Administration Medicine Training Electronics 98

PM360

JUNE 28, 2023

The Creative Floor Healthcare Awards was founded in 2014 by Shaheed Peera. Entries have come from the USA, Canada, South America, UK, EU, Australia, Japan, New Zealand, Philippines, Singapore, China, and the Middle East. The aim was to help change the way award shows are run.

Healthcare 52

Healthcare Healthcare Specialization 52

World of DTC Marketing

SEPTEMBER 17, 2020

In 2019, 12 states had obesity rates in the highest category for this survey (35 percent or greater), a jump from three states in 2014, and nine in 2018. More recent state-level data from the 2019 Behavioral Risk Factor Surveillance System (BRFSS) confirm the trend that adult obesity rates continue to climb.

Healthcare 242

Healthcare Healthcare Insurance Healthcare Provider 242

Pharma Marketing Network

JULY 17, 2023

He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group. Along the way, he has worked for the likes of Havas, Cushman & Wakefield and began a deep dive into the healthcare arena in 2009 when he joined Inventiv Health as Head of Digital & innovation.

Consulting 52

Consulting Education Networking Healthcare 52

World of DTC Marketing

SEPTEMBER 7, 2022

While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. COVID-19 has not impacted the number of launches in the oncology space, as 2020 and 2021 have seen similar rates of drug launches as in 2019.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. However, in 2014 Sanofi fired Viehbacher over a boardroom fight regarding his management.

Insurance 40

Insurance Doctors FDA Pharma 40